AbCellera Biologics Inc. ABCL Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s enterprise value?
- AbCellera Biologics Inc. (ABCL) reported enterprise value of $1.1B in Q1 2026.
- How has AbCellera Biologics Inc.'s enterprise value changed year-over-year?
- AbCellera Biologics Inc.'s enterprise value increased by 100.0% year-over-year, from $548.09M to $1.1B.
- What is the long-term trend for AbCellera Biologics Inc.'s enterprise value?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s enterprise value has grown at a -37.3% compound annual growth rate (CAGR), from $10.74B to $1.04B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.